Nutrients, vitamins and minerals as therapy
- 1 May 1979
- Vol. 43 (S5) , 2137-2142
- https://doi.org/10.1002/1097-0142(197905)43:5+<2137::aid-cncr2820430724>3.0.co;2-v
Abstract
Nutrients as therapy for patients with cancer are important as adjunctive therapy, i.e., adequate nutrition may be important for the success of whatever form of therapy is administered. Diets deficient in certain amino acids have some selectivity when tested against experimental tumors propagated in vivo. Such diets have had limited clinical trial and have been characterized by poor patient acceptance. Enzymes that produce deficiencies of certain amino acids, e.g., asparaginase, glutaminase, methioninase appear to offer a more reasonable approach to development of selective amino acid deficiencies in man. Trace metals in excessive amounts may be toxic or carcinogenic to the host. Two heavy metal salts, Cis-diamine dichloroplatinum and gallium nitrate, have recently been shown to have anti-neoplastic effects in man. There is no conclusive evidence that vitamins, administered in large doses, have significant antineoplastic effects although large doses of vitamin A, vitamin C, and vitamin B12 have been used for this purpose. In contrast, certain vitamin analogs such as folate antimetabolites can cause tumor regression and are useful clinical treatment. An enzyme, carboxypeptidase G1, by splitting naturally occurring folates, may also have promise as a method of producing enzymic folate deficiency.Keywords
This publication has 29 references indexed in Scilit:
- Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.Proceedings of the National Academy of Sciences, 1976
- Inhibition and Reversal by β-Retinoic Acid of Hyperplasia Induced in Cultured Mouse Prostate Tissue by 3-Methylcholanthrene or N -Methyl- N′ -nitro- N -nitrosoguanidine 2JNCI Journal of the National Cancer Institute, 1976
- Significance of Vitamins in CancerOncology, 1976
- The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChemico-Biological Interactions, 1974
- Ascorbic Acid and the GlycosaminoglycansOncology, 1973
- Enzymatic Cleavage of Methotrexate provides a Method for Prevention of Drug ToxicityNature, 1972
- L-AsparaginaseAnnual Review of Medicine, 1970
- Effects of reducing the phenylalanine-Tyrosine intake of patients with advanced malignant melanomaCancer, 1966
- TREATMENT OF LEUKqMIA BY AMINOACID IMBALANCEThe Lancet, 1965
- NeuroblastomaPediatric Clinics of North America, 1959